Cargando…
Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia
BACKGROUND: Thrombocytopenia, characterized by a diminished platelet count, emerged as the most frequently reported coagulation dysfunction event according to the FDA Adverse Event Reporting System (FAERS) database. In recent years, numerous clinical studies have investigated the potential link betw...
Autores principales: | Zhu, Yuanchao, Zhao, Fei, Jin, Pengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508280/ https://www.ncbi.nlm.nih.gov/pubmed/37732172 http://dx.doi.org/10.2147/IDR.S426259 |
Ejemplares similares
-
Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021) -
Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients
por: Hu, Juan, et al.
Publicado: (2020) -
Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023) -
Risk Factors and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome
por: Wang, Fei, et al.
Publicado: (2020) -
Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae
por: Jiang, Yuansu, et al.
Publicado: (2019)